NOVEL POLYFUNCTIONAL COMPOUND FOR PHARMACEUTICAL PURPOSE

PROBLEM TO BE SOLVED: To provide a novel polyfunctional compound for pharmaceutical purposes.SOLUTION: The present invention relates to a synthetic bifunctional non-antibody compound comprising one or more effector parts and one or more binder parts, where the effector part is operationally linked t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	ANDRE KOLTERMANN
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a novel polyfunctional compound for pharmaceutical purposes.SOLUTION: The present invention relates to a synthetic bifunctional non-antibody compound comprising one or more effector parts and one or more binder parts, where the effector part is operationally linked to the binder part via a linker, the effector part is a ligand for at least one pathogen pattern recognition receptor (PRR), and the binder part is bonded to a marker of a tumor cell. This effector is any substance introducing, regulating or mediating the immune response of a host or being involved in the immune response. In particular, the effector includes an immune response of a congenital immune system in particular.